SCHEMBL27647553

SCHEMBL27647553

Clc1c[c]ccc1Cl.[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL43352 0.97
Water SCHEMBL8015768 0.97
SCHEMBL27654076 0.94
SCHEMBL8672502 0.94
Zinc Chloride SCHEMBL29025482 0.89 LMNA (0.32)
SCHEMBL27917432 0.87 LMNA (0.30)
SCHEMBL28328512 0.87 LMNA (0.30)
SCHEMBL27621453 0.78
SCHEMBL1135190 0.77
SCHEMBL61531 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1972938-B Cyclic amine compound TAISHO PHARMACEUTICAL CO LTD 2010-09-29 CN disclosed
CN-100467468-C Triaza-spiropiperidine derivatives for use as GLYT-1 inhibitors in the treatment of neurological and neuropsychiatric disorders HOFFMANN LA ROCHE (CH) 2009-03-11 CN disclosed
CN-1972938-A Cyclic amine compound TAISHO PHARMACEUTICAL CO LTD (JP) 2007-05-30 CN disclosed
CN-1871238-A Triaza-spiropiperidine derivatives for use as GLYT-1 inhibitors in the treatment of neurological and neuropsychiatric disorders HOFFMANN LA ROCHE (CH) 2006-11-29 CN disclosed